Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12

Seminars in Oncology
Theofanis Floros, Ahmad A Tarhini

Abstract

Efforts over nearly four decades have focused on ways to use cytokines to manipulate the host immune response towards cancer cell recognition and eradication. Significant advances were achieved with interleukin-2 (IL-2) and interferon-α (IFN-α), primarily in the treatment of patients with melanoma and renal cell carcinoma. However, the utility of other cytokines showing promise in the preclinical setting has not been established largely because of toxicity, the complex functionality of each cytokine and the difficulty mimicking in preclinical models the human environment. Here, we review the basic biology and the clinical experiences with IFN-α, IL-2, IL-15, IL-21, and IL-12. We will also review ongoing clinical trials and discuss future directions including potential use of cytokines in combination with other effective immunotherapy approaches that have come of age in recent years.

References

Nov 14, 1997·Immunity·C B Thompson, J P Allison
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Omar EtonRobert S Benjamin
Nov 26, 2002·Science·Katsutoshi OzakiWarren J Leonard
Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
Oct 12, 2004·Cytokine·Sarah L Gaffen, Kathleen D Liu
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael AtkinsSabina Signoretti
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pierre L TriozziRobert M Conry
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ulrich KeilholzAlexander M M Eggermont
Feb 17, 2006·The New England Journal of Medicine·Helen GogasJohn M Kirkwood
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giovanni C CesanaHoward L Kaufman
Mar 23, 2006·Annual Review of Immunology·Averil MaPatrick Burkett
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stergios J MoschosJohn M Kirkwood
Oct 21, 2006·Journal of the American Academy of Dermatology·Madeleine DuvicAlain H Rook
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Omid HamidJeff S Weber
Jan 20, 2007·Blood·Rong ZengWarren J Leonard
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Diana C GallagherVikas P Sukhatme
Aug 30, 2008·International Journal of Cancer. Journal International Du Cancer·Carla M L van HerpenPieter H M De Mulder
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Nov 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adil I DaudRichard Heller
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marianna SabatinoHoward L Kaufman
Jun 11, 2009·Journal of the National Cancer Institute·Marna G BouwhuisUNKNOWN EORTC Melanoma Group and the Nordic Melanoma Group
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vito PistoiaIrma Airoldi
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierVesna Sneller
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian I RiniEric J Small
Apr 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michal J BesserJacob Schachter

❮ Previous
Next ❯

Citations

May 24, 2016·Nature Immunology·Rebecca B DelconteNicholas D Huntington
Jul 26, 2016·Disease Markers·Ángela MarrugalIrene Ferrer
Aug 1, 2016·Current Oncology Reports·Susanna A CurtisHarriet M Kluger
Jun 18, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Leisha A EmensFrancesco M Marincola
Jun 12, 2018·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kevin C ConlonThomas A Waldmann
Dec 24, 2015·Nature Reviews. Cancer·Maelig G Morvan, Lewis L Lanier
Mar 5, 2020·Nucleosides, Nucleotides & Nucleic Acids·Alexander N PrutkovYulia V Berezovskaya
Jul 8, 2020·International Journal of Molecular Sciences·Daniele LavacchiLorenzo Antonuzzo
Aug 16, 2019·Physiological Reviews·Carla Riera-DomingoMassimiliano Mazzone
Dec 22, 2016·CNS Oncology·Souvik Karmakar, Karlyne M Reilly
Mar 4, 2017·Mediators of Inflammation·Marina FabbiSilvano Ferrini
Oct 19, 2019·Journal of Clinical Medicine·Simona SivoriDaniela Pende
Jan 21, 2019·Archives of Pharmacal Research·Sung Min Cho, Ho Jeong Kwon
Aug 20, 2019·Immunotherapy·Faezeh GhaemdoustNima Rezaei
Dec 22, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marina A Dobrovolskaia
Mar 3, 2020·Frontiers in Immunology·Sara SaabHumam Kadara
Aug 6, 2020·Cancers·S Elizabeth FranksJames W Hodge
Dec 22, 2016·Immunotherapy·Giandomenico RovielloDaniele Generali
Apr 25, 2017·Journal of Hematology & Oncology·Tala Achkar, Ahmad A Tarhini
Jun 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Margareta P CorreiaAdelheid Cerwenka
Jul 27, 2018·Frontiers of Medicine·Fang FangZhigang Tian
Mar 27, 2019·Journal for Immunotherapy of Cancer·Paul T Finger, Anna C Pavlick
Jul 7, 2017·Investigative and Clinical Urology·Yang Hyun ChoEu Chang Hwang
Sep 26, 2019·Frontiers in Immunology·Sarah E ClarkLaurel L Lenz
Dec 20, 2017·Experimental Biology and Medicine·Christian FercherRoss T Barnard
Oct 14, 2020·Biomaterials Science·Oluwaseyi T Shofolawe-BakareThomas A Werfel
Feb 21, 2018·Cancer Immunology Research·Michael DouganStephanie K Dougan
Nov 14, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ahmad A TarhiniJohn M Kirkwood
Jan 16, 2020·Immunity·Jackson G EgenLawren C Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Medicinal Chemistry
G K Antony, A Z Dudek
Nature Reviews. Drug Discovery
Kresten SkakPallavur V Sivakumar
Cytokine & Growth Factor Reviews
Todd A FehnigerMichael A Caligiuri
Cytokine & Growth Factor Reviews
Geok Choo Sim, Laszlo Radvanyi
© 2021 Meta ULC. All rights reserved